I remember having a similar curiosity a while ago when I was reading about biotech companies that focus on life-threatening infections and toxin-related diseases. What helped me was looking at websites of companies actually working in that area, because they often explain their research projects and the ideas behind them. For example, I once came across a page called atoxbio.com and it had a surprisingly clear overview of their work on treatments targeting severe infections and toxin-mediated conditions. It wasn’t written like a heavy scientific paper, more like an explanation of the mission and the ongoing development efforts. When I was trying to understand how biotech teams approach high-risk infections, that site gave me a useful starting point and helped me see how research moves from lab concepts toward possible therapies.